ISIN | LU0396226531 |
---|---|
Valor Number | 4761030 |
Bloomberg Global ID | BBG000MCQCZ5 |
Fund Name | Europe Index -R dy GBP |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Distribution |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | To achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 163.44 GBP | 14.04.2025 |
---|---|---|
Previous Price * | 160.43 GBP | 11.04.2025 |
52 Week High * | 176.46 GBP | 06.03.2025 |
52 Week Low * | 154.05 GBP | 07.04.2025 |
NAV * | 163.44 GBP | 14.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 863,260,928 | |
Unit/Share Assets *** | 341,517 | |
Trading Information SIX |
YTD Performance | +3.48% |
31.12.2024 - 14.04.2025
31.12.2024 14.04.2025 |
---|---|---|
YTD Performance (in CHF) | -1.36% |
31.12.2024 - 14.04.2025
31.12.2024 14.04.2025 |
1 month | -6.10% |
14.03.2025 - 14.04.2025
14.03.2025 14.04.2025 |
3 months | +1.16% |
14.01.2025 - 14.04.2025
14.01.2025 14.04.2025 |
6 months | -3.34% |
14.10.2024 - 14.04.2025
14.10.2024 14.04.2025 |
1 year | -0.02% |
15.04.2024 - 14.04.2025
15.04.2024 14.04.2025 |
2 years | +4.18% |
14.04.2023 - 14.04.2025
14.04.2023 14.04.2025 |
3 years | +14.13% |
14.04.2022 - 14.04.2025
14.04.2022 14.04.2025 |
5 years | +49.23% |
14.04.2020 - 14.04.2025
14.04.2020 14.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
SAP SE | 2.41% | |
---|---|---|
Nestle SA | 2.32% | |
ASML Holding NV | 2.26% | |
Roche Holding AG | 2.02% | |
AstraZeneca PLC | 1.97% | |
Shell PLC | 1.95% | |
Novo Nordisk AS Class B | 1.92% | |
Novartis AG Registered Shares | 1.91% | |
HSBC Holdings PLC | 1.77% | |
Siemens AG | 1.52% | |
Last data update | 31.03.2025 |
TER *** | 0.752% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 0.76% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |